An observational study in Safety, Efficiency and Electrocautery, sponsored by Tanta University. Completed at 1 site in Egypt. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-03-24.
Sponsored by Tanta University · Observational
The aim of this study is to evaluate safety and efficiency of electrocautery de-epithelization in mammoplasty.
Mammoplasty is the fifth most commonly performed by plastic surgeons worldwide to improve symptomatology resulting from macromastia.
One of the key stages in a breast reduction or augmentation surgery is the de-epithelization process. De-epithelialization is the first stage of reduction mammoplasty in techniques that use dermal, dermo-glandular pedicles. Traditional methods of de-epithelization include manual dissection or mechanical scraping as time-consuming and demanding by most surgeons, especially when the breasts are large and when there is no assistant available.
Tanta University is the lead sponsor of 963 studies on the registry; 304 are open to participants now.
Of its 16 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
This retrospective study was conducted on 100 females patients aged 18 years or older who were scheduled to undergo mammoplasty at Tanta University Hospitals, Egypt between July 2024 and February 2025
Exclusion Criteria:
Patients undergoing standard surgical de-epithelization with electrocautery.
Procedure: Electrocautery
Patients undergoing standard surgical de-epithelization using surgical blade by scalpel.
Procedure: Surgical blade by scalpel
Patients undergoing standard surgical de-epithelization with electrocautery.
Patients undergoing standard surgical de-epithelization using surgical blade by scalpel.
Operative time
Operative time (time taken from skin incision to completion of skin closure). Operative time will be measured for each breast
Time frame: Intraoperatively
Degree of pain
Degree of pain will be measured using a standard 10-point visual analog pain scale (VAS). The women verbally reported a pain rating for each breast first in the recovery room (within 4 hours of surgical stop) and again at the first follow-up visit (1 to 3 days after surgery).
Time frame: 3 days after surgery
De-epithelization time
De-epithelization time will be recorded.
Time frame: Intraoperatively
Time to achieve hemostasis
The time to achieve hemostasis will be assessed.
Time frame: Intraoperatively
Duration of drain placement
Duration of drain placement will be recorded.
Time frame: Intraoperatively
Blood loss
Blood loss will be assessed by weighing the swabs that will be used during the pedicle de-epithelialization process.
Time frame: Intraoperatively
Wound healing time
Wound healing time will be recorded.
Time frame: 6 weeks after surgery
Incidence of adverse events
The incidence of adverse events such as flap necrosis, hematoma, seroma, and surgical site infection will be recorded.
Time frame: 6 weeks after surgery
Plan to share: Yes — The data will be available upon a reasonable request from the corresponding author after the end of study for one year.
Supporting information: Study protocol
No publications or documents are linked to this record.
This study is completed, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Tanta University